Data also shows more strokes in younger people with COVID
The COVID-19 Stroke Study Group’s latest report, published in the journal Stroke, focused on a group of 432 patients from 17 countries diagnosed with COVID-19 and stroke. Among this group, the study found a significantly higher incidence of large vessel occlusion (LVO) — strokes caused by a blockage in one of the brain’s major arteries that are typically associated with more severe symptoms. Nearly 45% of strokes in the study group were LVOs; in the general population, 24 to 38% of ischemic strokes are LVOs.
The study group also had a high percentage of young patients who had strokes: more than a third were younger than 55, and nearly half were younger than 65. Pre-pandemic general population data showed 13% of strokes occurred in people under 55, and 21% in people younger than 65.
The data showed that that less-severe strokes, mostly in critically ill patients or overwhelmed health centers, were underdiagnosed. This finding is significant, the research team said, as minor or less-severe stroke may be an important risk factor for a more severe stroke in the future.
“Our observation of a higher median stroke severity in countries with lower healthcare spending may reflect a lower capacity for the diagnosis of mild stroke in patients during the pandemic, but this may also indicate that patients with mild stroke symptoms refused to present to the hospitals,” said Ramin Zand, M.D., a vascular neurologist and clinician-scientist at Geisinger and leader of the study group.
Throughout the pandemic, people with COVID-19 have reported symptoms involving the nervous system, ranging from a loss of smell or taste to more severe and life-threatening conditions such as altered mental state, meningitis and stroke. A group of Geisinger scientists and a team of experts from around the world formed the COVID-19 Stroke Study Group shortly after the pandemic began to study the correlation between COVID-19 infection and stroke risk.
Results from the first phase of the study, which included data on 26,175 patients, indicated an overall stroke risk of 0.5% to 1.2% among hospitalized patients with COVID-19 infection. The finding demonstrated that, even though there were increasing reports of patients with COVID-19 experiencing stroke, the overall risk is low.
“Our initial data showed that the overall incidence of stroke was low among patients with COVID-19, and while that hasn’t changed, this new data shows that there are certain groups of patients — for example, younger patients — who are more affected,” said Vida Abedi, Ph.D., a scientist in the department of molecular and functional genomics at Geisinger. “We hope these findings highlight new research directions to better identify patients at risk and help improve the quality of care.”
Geisinger has an exciting research environment with more than 50 full-time research faculty and more than 30 clinician scientists. Areas of expertise include precision health, genomics, informatics, data science, implementation science, outcomes research, health services research, bioethics and clinical trials.
Geisinger is committed to making better health easier for the more than 1 million people it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes 10 hospital campuses, a health plan with more than half a million members, a Research Institute and the Geisinger Commonwealth School of Medicine. With nearly 24,000 employees and more than 1,700 employed physicians, Geisinger boosts its hometown economies in Pennsylvania by billions of dollars annually. Learn more at Facebook, Instagram, LinkedIn and Twitter.
For media inquiries:
Ashley Andyshak Hayes
Marketing & Communications